Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  09/13/2005
 
Trade Name:  NovoLog
 
Generic Name or Proper Name (*):  insulin aspart recombinant injection
 
Indications Studied:  Diabetes Mellitus
 
Label Changes Summary:  In clinical studies comparing NovoLog to regular human insulin in patients 2 to 18 years with type 1 diabetes, NovoLog achieved glycemic control comparable to regular human insulin The incidence of hypoglycemia was similar for both treatment groups
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Novo Nordisk
 
Pediatric Exclusivity Granted Date:  05/24/2005
 
NNPS:  FALSE'
 
Therapeutic Category:  Antidiabetic
 
-
-